These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 31543505)

  • 1. A unique tau conformation generated by an acetylation-mimic substitution modulates P301S-dependent tau pathology and hyperphosphorylation.
    Ajit D; Trzeciakiewicz H; Tseng JH; Wander CM; Chen Y; Ajit A; King DP; Cohen TJ
    J Biol Chem; 2019 Nov; 294(45):16698-16711. PubMed ID: 31543505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An acetylation-phosphorylation switch that regulates tau aggregation propensity and function.
    Carlomagno Y; Chung DC; Yue M; Castanedes-Casey M; Madden BJ; Dunmore J; Tong J; DeTure M; Dickson DW; Petrucelli L; Cook C
    J Biol Chem; 2017 Sep; 292(37):15277-15286. PubMed ID: 28760828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Dual Pathogenic Mechanism Links Tau Acetylation to Sporadic Tauopathy.
    Trzeciakiewicz H; Tseng JH; Wander CM; Madden V; Tripathy A; Yuan CX; Cohen TJ
    Sci Rep; 2017 Mar; 7():44102. PubMed ID: 28287136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies.
    Irwin DJ; Cohen TJ; Grossman M; Arnold SE; Xie SX; Lee VM; Trojanowski JQ
    Brain; 2012 Mar; 135(Pt 3):807-18. PubMed ID: 22366796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cornel Iridoid Glycoside Regulates Modification of Tau and Alleviates Synaptic Abnormalities in Aged P301S Mice.
    Yang CC; Luo Y; Guo KW; Zheng CC; Li L; Zhang L
    Curr Med Sci; 2020 Dec; 40(6):1040-1046. PubMed ID: 33428131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piericidin A aggravates Tau pathology in P301S transgenic mice.
    Höllerhage M; Deck R; De Andrade A; Respondek G; Xu H; Rösler TW; Salama M; Carlsson T; Yamada ES; Gad El Hak SA; Goedert M; Oertel WH; Höglinger GU
    PLoS One; 2014; 9(12):e113557. PubMed ID: 25437199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy.
    Shi Y; Yamada K; Liddelow SA; Smith ST; Zhao L; Luo W; Tsai RM; Spina S; Grinberg LT; Rojas JC; Gallardo G; Wang K; Roh J; Robinson G; Finn MB; Jiang H; Sullivan PM; Baufeld C; Wood MW; Sutphen C; McCue L; Xiong C; Del-Aguila JL; Morris JC; Cruchaga C; ; Fagan AM; Miller BL; Boxer AL; Seeley WW; Butovsky O; Barres BA; Paul SM; Holtzman DM
    Nature; 2017 Sep; 549(7673):523-527. PubMed ID: 28959956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral transcriptome analysis reveals age-dependent progression of neuroinflammation in P301S mutant tau transgenic male mice.
    Kim J; Selvaraji S; Kang SW; Lee WT; Chen CL; Choi H; Koo EH; Jo DG; Leong Lim K; Lim YA; Arumugam TV
    Brain Behav Immun; 2019 Aug; 80():344-357. PubMed ID: 30980950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural Functions and Cerebral Blood Flow in a P301S Tauopathy Mouse Model: A Time-Course Study.
    Ahmad F; Mein H; Jing Y; Zhang H; Liu P
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tauopathy-associated tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model.
    Guha S; Fischer S; Johnson GVW; Nehrke K
    Mol Neurodegener; 2020 Nov; 15(1):65. PubMed ID: 33168053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex Impact on Tau-Aggregation and Postsynaptic Protein Levels in the P301L Mouse Model of Tauopathy.
    Buccarello L; Grignaschi G; Castaldo AM; Di Giancamillo A; Domeneghini C; Melcangi RC; Borsello T
    J Alzheimers Dis; 2017; 56(4):1279-1292. PubMed ID: 28157099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau-positive nuclear indentations in P301S tauopathy mice.
    Fernández-Nogales M; Santos-Galindo M; Merchán-Rubira J; Hoozemans JJM; Rábano A; Ferrer I; Avila J; Hernández F; Lucas JJ
    Brain Pathol; 2017 May; 27(3):314-322. PubMed ID: 27338164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Argyrophilic grain disease differs from other tauopathies by lacking tau acetylation.
    Grinberg LT; Wang X; Wang C; Sohn PD; Theofilas P; Sidhu M; Arevalo JB; Heinsen H; Huang EJ; Rosen H; Miller BL; Gan L; Seeley WW
    Acta Neuropathol; 2013 Apr; 125(4):581-93. PubMed ID: 23371364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An HDAC6-dependent surveillance mechanism suppresses tau-mediated neurodegeneration and cognitive decline.
    Trzeciakiewicz H; Ajit D; Tseng JH; Chen Y; Ajit A; Tabassum Z; Lobrovich R; Peterson C; Riddick NV; Itano MS; Tripathy A; Moy SS; Lee VMY; Trojanowski JQ; Irwin DJ; Cohen TJ
    Nat Commun; 2020 Nov; 11(1):5522. PubMed ID: 33139698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Lys 280 → Gln mutation mimicking disease-linked acetylation of Lys 280 in tau extends the structural core of fibrils and modulates their catalytic properties.
    Kumar H; Udgaonkar JB
    Protein Sci; 2021 Apr; 30(4):785-803. PubMed ID: 33496017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for accelerated tauopathy in the retina of transgenic P301S tau mice exposed to repetitive mild traumatic brain injury.
    Xu L; Ryu J; Nguyen JV; Arena J; Rha E; Vranis P; Hitt D; Marsh-Armstrong N; Koliatsos VE
    Exp Neurol; 2015 Nov; 273():168-76. PubMed ID: 26311071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau pathology is present in vivo and develops in vitro in sensory neurons from human P301S tau transgenic mice: a system for screening drugs against tauopathies.
    Mellone M; Kestoras D; Andrews MR; Dassie E; Crowther RA; Stokin GB; Tinsley J; Horne G; Goedert M; Tolkovsky AM; Spillantini MG
    J Neurosci; 2013 Nov; 33(46):18175-89. PubMed ID: 24227726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glimepiride mitigates tauopathy and neuroinflammation in P301S transgenic mice: role of AKT/GSK3β signaling.
    Zaki MO; El-Desouky S; Elsherbiny DA; Salama M; Azab SS
    Inflammopharmacology; 2022 Oct; 30(5):1871-1890. PubMed ID: 35922737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylation mimic of lysine 280 exacerbates human Tau neurotoxicity in vivo.
    Gorsky MK; Burnouf S; Dols J; Mandelkow E; Partridge L
    Sci Rep; 2016 Mar; 6():22685. PubMed ID: 26940749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.